. The soluble Klotho products serve as circulating factors that are involved in multiple signaling pathways (13) . Klotho is reported to be implicated in tumor suppression (34) and renal hypertrophy (20) by binding to cell-surface receptors of insulin and insulin-like growth factor 1 and thereby repressing their intracellular signaling pathways (15) . Klotho is also reported to inhibit Wnt signaling activity by forming a complex with Wnt3 (16) . Wnt signaling is activated in the process of tubulointerstitial renal fibrosis, a key feature of chronic kidney disease, after unilateral ureteral obstruction (UUO; Ref. 31 ). This tubulointerstitial renal fibrosis is revealed to be ameliorated by a Wnt antagonist (9) , whereas the mechanism remains obscure.
Cell cycle gap 2/mitosis (G 2 /M) arrest of proximal tubular epithelial cells was identified recently as a key event in kidney fibrosis (35) . Cells arrested in the G 2 /M phase of the cell cycle produce high quantities of growth factors including tissue growth factor (TGF)-␤ and connective tissue growth factor (CTGF), the cytokines that are known to play a critical role in the pathogenesis of a wide variety of renal diseases, including tubulointerstitial diseases (7, 27, 36) . Activation of Wnt/␤-catenin signaling induces cell cycle arrest at the G 2 /M phase (4, 23) . The main hypothesis tested in this study was that the Klotho inhibits fibrosis by controlling the G 2 /M phase cell cycle via inhibition of Wnt/␤-catenin signaling. For this purpose, we investigated the effects of Klotho on kidney fibrosis in Klotho-overexpressing mice, or mice transfected with Klotho expression plasmid, subjected to UUO. We also investigated the role of Wnt/␤-catenin signaling in cell cycle control and the effect of Klotho on G 2 /M cell cycle arrest.
METHODS
Animal model. Mice that overexpress Klotho under the control of the human elongation factor 1␣ promoter EFmKL46 (15) (KLTG) generated by Makoto Kuro-o (University of Texas Southwestern Medical Center) were kindly provided by Yo-Ichi Nabeshima (Kyoto University, Kyoto, Japan). KLTG were backcrossed Ͼ10 ten times onto the C57/BL6 strain. Klotho heterozygous mutant mice (KLhe), purchased from CLEA Japan (Tokyo, Japan), were backcrossed Ͼ10 times onto the C57/BL6 strain. Mice with this transgene express nuclear ␤-galactosidase under control of the ␤-catenin-activated transgene promoter (BAT-LacZ; Ref. 21) were provided by Terry P. Yamaguchi (National Cancer Institute-Frederick). To monitor Wnt signaling in vivo, KLTG and KLhe were mated with BAT-LacZ. For all animal experiments, littermates (WT; wild-type/BAT-LacZ) were used as control animals. UUO was induced by ligation of the left ureter, as described previously (26) . Sham operation included anesthesia, abdominal incision, and dissection of the ureter but no ureteric ligation. At 3, 7, and 14 days after UUO, the mice were killed and the kidneys were extracted carefully and weighed. Blood samples were obtained at the time of death for measurement of serum creatinine and blood urea nitrogen using enzymatic methods. All animals were cared for in accordance with the guidelines set forth by the Committee on Laboratory Resources, National Institutes of Health, and Guide for the Care and Use of Laboratory Animals of Kawasaki Medical School.
In vivo muscle electroporation. Intramuscular injection of plasmid DNA followed by electroporation was performed according to a commonly used protocol (19) . In each mouse, 20 g DNA in 40 l PBS were injected into each tibialis anterior muscle (bilaterally), using a 27-gauge needle. Immediately after the injection, three electrical pulses (50 V, 50-ms duration at 100-ms intervals) were delivered using an in vivo electroporator (model CUY21; NEPA GENE, Chiba, Japan) to the muscle. The polarity was then reversed, and a further three pulses were delivered to the muscle.
Histological analysis. Kidney sections (4-m thick) were prepared from paraffin-embedded tissues and stained with Masson-trichrome. The severity of tubulointerstitial injury was evaluated by examining 10 fields in randomly selected tissue samples. Blue-stained scarred areas were quantified by a color image analyzer (Win ROOF; Mitani, Fukui, Japan). Glomeruli, tubules, and blood vessels of the cortex were excluded. Results are expressed as a percentage of the relative volume of the scanned interstitium.
Immunohistochemistry. Serial sections (4-m thick) of paraffinembedded specimens were rehydrated in PBS and subjected to antigen retrieval in a microwave. Antibodies against fibronectin (FN) and vimentin (Santa Cruz Biotechnology, Santa Cruz, CA) were used as the primary antibodies, and detection was carried out by using the DAKO EnVisionϩ system and diaminobenzidine reagent (Dako Japan, Kyoto, Japan).
Real-time quantitative RT-PCR. Total mRNA extraction and realtime quantitative RT-PCR were performed as described previously (25) . Briefly, total RNA was prepared from the kidney by using TRIzol (Life Technologies, Gaithersburg, MD) followed by digestion with DNase (Sigma Aldrich, St. Louis, MO) to eliminate any contamination of genomic DNA. First, the cDNA strand was synthesized from total RNA (1 mg) by Moloney murine leukemia virus reverse transcriptase (Life Technologies) with oligo(dT)12-18 as a primer. The primers and probes for TaqMan analysis were designed with Primer 3 online software (http://frodo.wi.mit.edu/primer3/; accessed 1 April 2012) based on the sequence information from GenBank. Primers and probes are as follows: Klotho (NM_013823)-forward, TTGGGT-CACTGGGTCAATCTC; Klotho-reverse, CCGGCACGATAGGT-CATGTT; Klotho-probe, ATCACCATGAACGAGCCAAACACA-CG; CTGF (NM_010217)-forward, TACCGTGGGAGGAACTAT-CC; CTGF-reverse, CTCACCTCAGTGTGCGTTCT; CTGF-probe, CAGTTGTTCATTAGCGCACAGTGCC; TGF-␤ (NM_011577)-forward, ACCTGCAAGACCATCGACATG; TGF-␤-reverse, CGAGCCTT-AGTTTGGACAGGAT; TGF-␤-probe, AAGCGCATCGAAGCCA-TCCGTG; collagen type III (Col3: NM_009930)-forward, ATCTAT-GAATGGTGGTTTTCAGTT; Col3-reverse, TTTTGCAGTGGTATG-TAATGTTCT; Col3-probe, CTTCTTTCCAGCCGGGCCTC; fibronectin 1 (FN1: NM_010233)-forward, ATGATGAGGTGCACGTGTGT; FN1-reverse, TGACGCTTGTGGAACGTGT; FN1-probe, TCGTG-GAGAATGGGCATGCA; myelocytomatosis oncogene (cMyc: NM_ 010849)-forward, CCACGTCTCCACTCACCA; cMyc-reverse, GAG-CACTTGCGGTTGTTG; cMyc-probe, CCAGCTGCCAAGAGGGCCA; Wnt-inducible signaling protein 1 (WISP1: NM_018865)-forward, CA-GATGGCTGTGAATGCTGT; WISP1-reverse, TGTGCACACACTCCT-ATTGC; WISP1-probe, CACCGGGGCCTCTACTGCGA. The expression level in each sample was expressed according to that of the housekeeping gene GAPDH RNA.
Target labeling and hybridization to microarray. For control and test RNA, the synthesis of target cRNA probes and hybridization were performed using Agilent's Low RNA Input Linear Amplification kit (Agilent Technologies, Palo Alto, CA) according to the instructions supplied by the manufacturer. Amplified and labeled cRNA was purified on RNase minicolumn (Qiagen, Hilden, Germany) according to the protocol provided by the manufacturer. Cy3-labeled and Cy5-labeled cRNA target were mixed, and the fragmentation of cRNA was performed by adding 10ϫ blocking agent and 25ϫ fragmentation buffer followed by incubation at 60°C for 30 min. The fragmented cRNA was resuspended with 2ϫ hybridization buffer and directly pipetted onto assembled Agilent Whole Mouse Genome microarray (Agilent Technologies). The array was hybridized at 65°C for 17 h using an Agilent Hybridization oven (Agilent Technologies).
Microarray data acquisition and analysis. The hybridization images were analyzed by Agilent DNA Microarray Scanner (Agilent Technologies), and the data quantification was performed using Agilent Feature Extraction software version 9.5.3.1 (Agilent Technologies). The average fluorescence intensity for each spot was calculated, and the local background was subtracted. All data normalization and selection of fold-changed genes were performed using GeneSpringGX 7.3.1 (Agilent Technologies). Genes were filtered with removal of flag-out genes in each experiment. Intensity-dependent normalization (LOWESS) was performed, where the ratio was reduced to the residual of the Lowess fit of the intensity vs. ratio curve. The averages of normalized ratios were calculated by dividing the average of normalized signal channel intensity by the average of normalized control channel intensity. Functional annotation of genes was performed according to Gene Ontology Consortium (http://www.geneontology.org/index. shtml) by GeneSpringGX 7.3.1.
Measurement of ␤-galactosidase activity. ␤-Galactosidase staining was performed with a ␤-galactosidase staining kit (Cell Bolabs, San Diego, CA) according to the manual sheet provided by the manufacturer. The percentage of the ␤-galactosidase-positive area was measured by using a color image analyzer. Twenty consecutive fields from each of the mouse kidney were randomly evaluated at a magnification of ϫ100. ␤-Galactosidase activity was examined using a mammalian ␤-galactosidase assay kit (Thermo Scientific, Rockford, IL).
Protein preparation and immunoblotting. The kidney and cell lysates were extracted as described previously (8) . Protein samples (20 g per lane) were subjected to immunoblotting analysis using antibody against ␤-catenin, cyclin B, and cyclin D from Cell Signaling Technology (Danvers, MA) and antibodies against GAPDH from Santa Cruz Biotechnology (Santa Cruz, CA). Antibody against Klotho (KM2076; provided by Kyowa Hakko Kirin, Tokyo, Japan), antibodies against FN and vimentin from Santa Cruz Biotechnology, and antibodies against c-Jun N-terminal kinase (JNK) and phospho-JNK from Cell Signaling Technology were also used for additional immunoblotting. Detection of serum klotho was performed by immunoprecipitation with anti-klotho antibody followed by immunoblotting with same anti-Klotho antibody. Signals were detected by using enhanced chemiluminescence system (GE Healthcare Japan, Tokyo, Japan).
Measurement of Rac1 activation. Activated Rac1 was measured by p21-binding domain of p21-activated protein kinase 1 pull-down assay (Thermo Scientific, Rockford, IL) according to the protocol provided by the manufacturer.
Cell culture and treatment. The HEK293 cells (TOYOBO Life Science, Osaka, Japan) were cultured in DMEM supplemented with 10% FBS. Cells were transfected with plasmid-encoding mouse Klotho (pKL) (20) or control LacZ expression vector (pLacZ) by using Lipofectamine 2000 (Life Technologies Japan) according to the instructions supplied by the manufacturer. After 48 h, the supernatants were collected and used as Klotho-or control-conditioned medium. Subconfluent HEK293 cells were synchronized using a double-thymidine block protocol (16 h of 2.5 mM thymidine block and 6 h of release and followed by another 16-h incubation with thymidine). After release from the block by medium change to klotho-or controlconditioned medium with recombinant 150 ng/ml Wnt3a (R&D Systems, Minneapolis, MN) or 0.1% BSA-PBS, the cell cycle profile was determined by fluorescence-activated cell sorting analysis and Western blot analysis.
Fluorescence-activated cell sorting analysis. Cells were prepared for propidium iodide staining using a Cycle test plus DNA reagent kit (Becton Dickinson, Franklin Lakes, NJ). DNA content was determined with a FACSCaliber (Becton Dickinson).
Statistical analysis. Values are expressed as means Ϯ SE. Intergroup differences were evaluated with the Mann-Whitney's U-test or Kruskal-Wallis test, as appropriate. Post hoc analysis used the Dun- nett's test. Survival curves were plotted by the Kaplan-Meier method, and differences were evaluated by log-rank tests. A P value of Ͻ0.05 was considered statistically significant.
RESULTS
Renal fibrosis is attenuated in Klotho transgenic mice after UUO. First, we examined the alterations in Klotho expression after UUO. Klotho mRNA expression (Fig. 1A) and protein expression (Fig. 1B) gradually decreased after UUO in WT mice. In contrast, the expression levels were both two-to threefold higher in KLTG at baseline, compared with WT and did not change after UUO.
UUO did not result in any change in blood urea nitrogen and serum creatinine levels in both WT and KLTG after UUO (Table 1) . Histopathologically, UUO resulted in enlargement of the renal pelvis and thinning of the renal cortex in WT mice ( Fig. 2A) . These changes were milder in KLTG after UUO ( Fig. 2A) . The weight of the obstructed kidney was lower at UUO day 14 in WT, relative to the sham, but such renal atrophy was not observed in KLTG mice (Fig. 2B) . Progressive tuburointerstitial fibrosis and tubular atrophy were detected in WT mice; at UUO day 14, quantitative analysis showed increased area of fibrous material in the interstitial space in WT mice (Fig. 2, C and D) . In contrast, augmented interstitial fibrosis and tubular atrophy were significantly alleviated in the KLTG. In fact, the area of fibrosis at UUO day 14 was significantly lower in KLTG compared with WT mice (Fig.  2D) . After UUO, the mRNA levels of profibrotic genes, CTGF, TGF-␤, and Col3 (Fig. 2, E-G) in the obstructed kidney of WT mice were enhanced compared with sham control mice. However, mRNA of these genes were significantly attenuated in KLTG. The number of interstitial cells that expressed vimentin, a mesenchymal marker, increased in the UUO-WT kidneys (Fig. 3) . The vimentin-positive area (Fig. 3A) and the protein expression levels (Fig. 3B) were significantly higher in UUO-WT compared with UUO-KLTG mice.
Wnt signaling is attenuated in Klotho transgenic mice after UUO. To determine whether canonical ␤-catenin signaling is activated in the UUO kidney tissues, we examined WT mice and KLTG mice crossed with BAT-LacZ mice. ␤-Galactosidase-positive tubular cells were found in UUO-WT kidney at post-UUO day 3 (Fig. 4A) , indicating active Wnt/␤-catenin signaling in tubular cells after UUO. The ␤-galactosidasepositive area in the UUO kidney (Fig. 4B) and renal ␤-galactosidase activity (Fig. 4C) were significantly increased in WT but not in KLTG mice. The increase in ␤-catenin expression after UUO in WT was also attenuated in KLTG (Fig. 4D) , indicating decreased Wnt signaling in UUO-KLTG kidney. Previous studies demonstrated the involvement of certain Wntinducible genes in renal fibrosis (9, 31) . We examined the expression of FN1, cMyc, and WISP1 after UUO (Fig. 4 , E-G). The expression levels of all of these genes were significantly increased after UUO in WT whereas they were attenuated in KLTG. A proportion of tubular cells expressed FN1 in the UUO-WT kidney (Fig. 5) . The FN1-positive area (Fig. 5A ) and the protein expression levels (Fig. 5B) were significantly reduced after UUO in KLTG compared with WT. We also analyzed Wnt signaling after UUO by microarray data (Fig. 6A) . The mRNA expression levels of Wnt signaling components in sham-operated kidneys of KLTG mice were lower compared with those of sham-WT mice (Fig. 6B) . UUO increased the mRNA expression levels in WT (Fig. 6C) but not in KLTG (Fig. 6D) , indicating that UUO reduces Wnt signaling in KLTG.
Wnt noncanonical pathway is attenuated in Klotho transgenic mice after UUO. To determine whether Wnt noncanonical signaling is activated in the UUO kidney tissues, we examined rac1 activity (Fig. 7A ) and JNK phosphorylation (Fig. 7B) . Western blot analysis for active Rac1 indicated that Rac1 activity was increased after UUO. The activation of JNK was also increased after UUO. Both activities were attenuated in KLTG compared with WT (Fig. 7, A and B) .
Wnt signaling is enhanced in Klotho heterozygous mutant mice after UUO. We investigated whether the secreted form of Klotho protein could affect tuburo-interstitial injuries after UUO. For this purpose, we used KLhe, and pKL was transferred into the skeletal muscle by electroporation. To examine the effectiveness of Klotho gene transfer, we evaluated the survival rate of pKL-transfected Klotho mutant mice (Fig. 8A) . The Klotho mutant mice died at an average age of 8 wk, as described previously (14) , whereas pKL transfection extended the duration of survival by ϳ4 wk. The serum Klotho levels in KLhe mice were about half that of the WT mice (Fig. 8B) . Furthermore, pKL transfection in KLhe increased serum Klotho levels more than WT.
Serum creatinine was slightly increased in KLhe mice after UUO but not in KLhe mice with pKL transfection ( Table 2) . The pKL transfection also improved renal morphological changes (Fig. 9A) . At day 14 of UUO, increased extracellular matrix deposition and tubulointerstitial fibrosis were noted in KLhe mice, compared with WT mice (Fig. 9, A and B) . At day 7 of UUO, Wnt activation in KLhe obstructed kidney was significantly higher than in WT mice (Fig. 9C) . Kidneys of pKL-transfected KLhe, however, had markedly reduced extracellular matrix deposition after UUO, and Wnt activation was significantly smaller than KLhe. The expression level of ␤-catenin in obstructed kidney was also higher in KLhe mice than WT mice and was reduced by pKL transfection (Fig. 9D) . At 7 days of UUO, the overexpression of CTGF, TGF-␤, and Col3 was noted in KLhe compared with WT mice (Fig. 10, A-C) . pKL transfection in muscle of KLhe significantly reduced the expression levels of the fibrosis-related genes in the obstructed kidney. Furthermore, the expression levels of Wnt/␤-catenin target genes (FN1, cMyc, and WISP1) were also increased in KLhe and reduced in pKL-transfected KLhe (Fig. 10, D-F) .
Reversal of Wnt-induced G 2 /M arrest by Klotho in HEK293 cells.
We examine the effect of Wnt on cell cycle and the effect of Klotho on this process. Cells were synchronized using a double thymidine block. After release from the block by medium change to control-conditioned medium, the percentage of cells at the G 2 /M phase was increased at 6 h and decreased at 18 h (Fig. 11A) . Stimulation with pKL-transfected condition medium alone did not affect this cell cycle pattern. However, Wnt3a stimulation prolonged the G 2 /M phase. After 18 h, the percentage of cells at the G 2 /M phase was still larger than stimulation with pLacZ-transfected condition medium. The increase in the percentage of cells at the G 2 /M phase at 18 h was normalized after costimulation with pKL-transfected condition medium (Fig. 11A) . The expression patterns of cell cycle proteins cyclin D1 and cyclin B1 were determined by Western blot (Fig. 11, B and C) . The expression ratio of cyclin B1 to cyclin D1, an indicator of the G 2 /M phase, was increased in Wnt3a-stimulated cells at 18 h and suppressed by costimulation with Klotho condition medium (Fig. 11C) . The expression levels of ␤-catenin were also increased by Wnt3a stimulation and reduced by coincubation with Klotho (Fig. 11, B and C) . The expression levels of the fibrosis-related genes CTGF and TGF-␤ increased significantly after stimulation of Wnt3a compared with the control condition media (Fig. 11, D and E) . Such increases were attenuated after coincubation with Klotho condition media.
DISCUSSION
The purpose of this study was to determine whether secretedtype Klotho protein reduces Wnt activation and, thereby, the development of renal fibrosis after UUO. The results of this study indicated that Wnt activation, which affects cell cycle by prolonging the G 2 /M phase, plays a critical role in the development of renal interstitial fibrosis. The G 2 /M-arrested proxi- mal tubular cells upregulate the release of profibrotic cytokines, such as TGF-␤ and CTGF, which subsequently stimulate transformation of fibroblasts to myofibroblast. KLTG and pKL-transfected mice with reduced Wnt activation showed a decrease or absence of all the above effects of Wnt on the renal fibrosis induced by UUO. These findings indicate that the secreted type of Klotho protein interacts with renal Wnt to inhibit renal fibrosis. Klotho could inhibit the progression of renal fibrosis, which is responsible for the progression of chronic kidney disease. Among the many fibrogenic factors that regulate renal fibrotic process, TGF-␤ is one that plays a central role (17) . TGF-␤ is a potent profibrotic cytokines. In the present study, we showed that Klotho inhibited Wnt-inducible TGF-␤ production itself. Conversely, inhibition of TGF-␤ by multiple strategies suppresses renal fibrotic lesions and prevents progressive loss of kidney function (5) . Klotho may suppress the TGF-␤ signaling both TGF-␤ expression levels and TGF-␤ receptor binding levels.
The results of the present study showed that overexpression of Klotho inhibited Wnt signaling both in vivo and in vitro. Wnt proteins play an essential role in organogenesis and tissue homeostasis in kidney, while reactivation and dysregulation of the Wnt signaling pathways underlie chronic fibrosis and progressive renal failure (22) . Previous studies demonstrated the involvement of Wnt/␤-catenin signaling pathway in the pathogenesis of renal fibrosis (9, 31) and that inhibition of Wnt signaling prevents or lessens fibrosis (9, 12) . Klotho could modulate Wnt signaling by direct binding, and the Wnt-Klotho interaction suppresses the biological activity of Wnt (16). The Wnt proteins constitute a large family of secreted glycoproteins that bind to the extracellular domain of Frizzled receptors (3) . The extracellular domain of Klotho protein, which is cleaved on cell surface, is composed of two internal repeats, KL1 and KL2, that share amino-acid sequence homology to ␤-glycosidase (14) . Although the precise mechanism of inhibitory effect on Wnt activity has not been elucidated, it is highly possible that the glycoprotein structure of Wnt could be modulated by binding to the secreted form of Klotho.
The results of the present study suggested the importance of the Wnt signal in the induction of G 2 /M cell cycle arrest and implication of this mechanism in the process leading to fibrosis. The G 2 /M phase-arrested cells overexpressed TGF-␤ and CTGF, which are known to promote the growth and activation of fibroblasts (35) . We confirmed that Klotho normalized cell cycle changes by suppression of Wnt activity and reduced TGF-␤ and CTGF production. Previous studies also described augmented tubular-cell number at the G 2 /M phase in the UUO model (35) . Although we did not examine the cell cycle distribution in the proximal tubular epithelial cells in vivo, Several mechanisms have been proposed for Wnt-mediated G 2 /M cell cycle arrest. The first involves activation of JNK by Wnt-noncanonical pathway. Wnt activates JNK and rac1 through noncanonical pathway, and these signaling pathways are widely conserved in both vertebrate and invertebrate (24) . Furthermore, activation of the JNK signaling has been reported to mediate cellular G 2 /M arrest (2, 35) . We examined rac1 and JNK activations as a Wnt-noncanonical pathway. Both activities were increased after UUO in WT but attenuated in KLTG. Thus this Wnt-noncanonical pathway may participate in G 2 /M cell cycle arrest. The second pathway is cMyc-induced G 2 /M cell cycle arrest pathway. cMyc is one of the main Wntinducible genes. We confirmed that UUO resulted in upregulation of cMyc in WT mice. Previous report suggests that cMyc induces G 2 /M arrest in mammary epithelial cells (28) . Thus increased cMyc expression by Wnt-canonical pathway may be involved in G 2 /M cell cycle arrest after UUO. The third pathway is the ␤-catenin/Forkhead box-O (FOXO) complex pathway. In general, Wnt activation induces the accumulation of ␤-catenin, forms ternary complexes with T-cell factor/ lymphoid enhancer factor transcription factors, and promotes specific gene expression. ␤-Catenin can also directly bind to FOXO transcription factors and enhances FOXO transcriptional activity in cells exposed to oxidative stress (6) . The FOXO transcription factor functions at the G 2 /M checkpoint to induce a delay in G 2 to M progression (32) . Since oxidative stress is increased in the interstitium of UUO kidneys (30) , it is possible that increased levels of ␤-catenin/FOXO complex may participate in G 2 /M cell cycle arrest after UUO.
In summary, the present study demonstrated that Wnt signaling pathway was activated after UUO and that Klotho protein inhibited this pathway and consequently reduced renal fibrosis. Klotho protein is a critical negative regulator of Wnt signaling and plays a negative regulatory role in the development of post-UUO renal fibrosis. These findings suggest that Klotho serves as therapeutic target for the treatment of chronic kidney disease. The Wnt pathway is widely implicated in pathogenesis of fibrotic diseases in diverse organs including lung, liver, and skeletal muscle. It is possible that the secreted form of Klotho protein exerts inhibitory effects on Wnt activations in these organs. Therefore, preservation of Klotho expression and secretion from kidney may substantially affect disease progression towards fibrosis in other organs. This hypothesis must be tested by conducting further investigations.
